Industry News
Pharmaceutical Industry News
Bavarian Nordic signs ‘larger’ monkeypox vaccine supply deal with unnamed country
Bavarian Nordic signs 'larger' monkeypox vaccine supply deal with unnamed country aliu Wed, 05/25/2022 - 08:38
Almirall, ramping up its Klisyri launch, wants patients to ‘listen to what your marks whisper to you’
Almirall, ramping up its Klisyri launch, wants patients to 'listen to what your marks whisper to you' badams Wed, 05/25/2022 - 05:13
ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it
ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it aliu Wed, 05/25/2022 - 04:39
PTSD treatment startup’s billboards speak to healthcare workers, first responders: ‘Your Trauma is Valid’
PTSD treatment startup's billboards speak to healthcare workers, first responders: 'Your Trauma is Valid' nmissakian Tue, 05/24/2022 - 21:54
Pfizer to expand Michigan manufacturing site to support Paxlovid rollout: report
Pfizer to expand Michigan manufacturing site to support Paxlovid rollout: report zbecker Tue, 05/24/2022 - 16:30
US to provide Bavarian Nordic’s vaccine Jynneos to some at risk for monkeypox, CDC says
US to provide Bavarian Nordic's vaccine Jynneos to some at risk for monkeypox, CDC says kdunleavy Tue, 05/24/2022 - 15:30
GSK ‘schemed’ FDA’s drug-device approval pathway to deflect asthma inhaler generics, lawsuit claims
GSK 'schemed' FDA's drug-device approval pathway to deflect asthma inhaler generics, lawsuit claims fkansteiner Tue, 05/24/2022 - 15:12
Bristol’s Abecma, Amgen’s Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA
Bristol's Abecma, Amgen's Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA aliu Tue, 05/24/2022 - 11:43
Moderna CEO Bancel uses inaugural stock option to give $355M to charity
Moderna CEO Bancel uses inaugural stock option to give $355M to charity fkansteiner Tue, 05/24/2022 - 11:15
In bankruptcy case, U.S. wants court to block J&J’s use of high-powered, highly paid lawyer Neal Katyal
In bankruptcy case, U.S. wants court to block J&J's use of high-powered, highly paid lawyer Neal Katyal kdunleavy Tue, 05/24/2022 - 11:14
In bankruptcy case, US wants court to block J&J’s use of high-powered, highly paid lawyer Neal Katyal
In bankruptcy case, US wants court to block J&J's use of high-powered, highly paid lawyer Neal Katyal kdunleavy Tue, 05/24/2022 - 11:14
Kala buys time by selling eye disease drugs to Alcon for $60M
Kala buys time by selling eye disease drugs to Alcon for $60M ntaylor Tue, 05/24/2022 - 10:26
J&J’s crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win zbecker Tue, 05/24/2022 - 10:17
With inhaled version of Tyvaso, United Therapeutics sniffs a potential blockbuster
With inhaled version of Tyvaso, United Therapeutics sniffs a potential blockbuster kdunleavy Tue, 05/24/2022 - 09:44
Zealand pumps up its prospects with late-phase rare disease hit
Zealand pumps up its prospects with late-phase rare disease hit ntaylor Tue, 05/24/2022 - 09:32
BD inks deal to work with syringe material at the sweet spot between glass and plastic
BD inks deal to work with syringe material at the sweet spot between glass and plastic ntaylor Tue, 05/24/2022 - 09:28
Teva recalls one lot of blood disorder med after testing flags capsule woes
Teva recalls one lot of blood disorder med after testing flags capsule woes fkansteiner Tue, 05/24/2022 - 09:23
Teva’s halt at troubled plant threatens to create shortages in wide range of injectable meds: report
Teva's halt at troubled plant threatens to create shortages in wide range of injectable meds: report jkeenan Tue, 05/24/2022 - 09:06
Dermavant looks to dethrone topical steroids with first FDA approval for Vtama in psoriasis
Dermavant looks to dethrone topical steroids with first FDA approval for Vtama in psoriasis fkansteiner Tue, 05/24/2022 - 06:56
Seagen’s potential breast cancer blockbuster Tukysa shows promise in colorectal cancer
Seagen's potential breast cancer blockbuster Tukysa shows promise in colorectal cancer kdunleavy Mon, 05/23/2022 - 11:15